国际麻醉学与复苏杂志   2011, Issue (1): 0-0
    
不同麻醉和镇痛方法对胸科手术胰岛素抵抗及相关因素影响的研究
刘伟, 苏跃, 田鸣, 耿万明, 张宗德1()
1.北京胸科医院
The investigation of insulin resistance to thoracic surgery with different anesthesia and analgesia and effects on correlative factors
 全文:
摘要:

【摘要】目的:研究不同麻醉和术后镇痛方式对胸科手术后胰岛素抵抗的影响及相关因素。方法:54例胸科手术病人随机分为两组,GA组29例,全麻+术后静脉镇痛;GEA组25例,全麻复合硬膜外麻醉+术后硬膜外镇痛。分别于麻醉前、术毕拔除气管导管后和术后第一天晨测定血浆超敏C反应蛋白(HCRP)、血糖(FPG) 、白介素6(IL-6)、抵抗素(RESIS)、胰岛素(FINS)的浓度和计算HOMA值。术后2h、6h、10h和术后一天VAS评分评估疼痛。结果:两组HCRP 、IL-6在术后一天时,与麻醉前和术毕分别比较均显著性增加(P<0.01)。两组FINS在术后一天时分别与术毕比较均显著增加(P<0.01),GA组从(20±10)升高到(30±12);GEA组从(18±7)升高到(26±10)。两组FPG在术毕和术后一天时分别与麻醉前比较均显著增加(P<0.01);术毕和术后一天时GEA组与GA组比较均显著性降低(P<0.05),分别为术毕(6.4±1.4)/(7.3±1.5)和术后一天(6.4±1.2)/(7.2±1.1)。两组HOMA值术后一天与麻醉前和术毕分别比较均显著性增加(P<0.01);HOMA值在术后一天时,GEA组与GA组比较显著性降低(P<0.05),为(2.0±1.1)/(2.3±1.6)。两组RESIS和VAS均无显著性差异。术毕时HOMA值与抵抗素和超敏C反应蛋白呈正相关(r=0.61),术后一天时HOMA值与抵抗素和白介素-6呈正相关(r=0.51)。结论:采用稳态模式(HOMA)评估法表明:(1)胸科手术应用全麻复合硬膜外麻醉和镇痛,术后一天提示可降低胰岛素抵抗。(2)术毕HOMA值与术毕时的抵抗素和超敏C反应蛋白呈正相关,术后一天HOMA值与术后一天时的抵抗素和白介素-6呈正相关。

关键词: 全身麻醉;硬膜外镇痛;胸外科手术;胰岛素抵抗;超敏C反应蛋白;白细胞介素-6;抵抗素
Abstract:

【Abstract】Objective To investigate insulin resistance to thoracic surgery with different anesthesia and analgesia and effects on correlative factors. Methods 54 ASAⅠ-Ⅱpatients undergoing thoracic surgery were randomized to receive either general anesthesia and PCIA (GA, n=29)or general anesthesia combined with epidural anesthesia and PCEA (GEA, n=25). Peripheral venous blood samples were taken before induction of anesthesia, at the end of surgery and on the morning of postoperative day 1, for determination of plasma hypersensitivity C-reactive protein(HCRP), blood glucose (FPG), interleukin-6(IL-6), resistin(RESIS) and insulin(FINS). Postoperative pain was assessed by VAS at the following time points:2h, 6h, 10h after operation and on the morning of postoperative day 1. While insulin resistance was assessed by Hemeostasis Model Assessment(HOMA). The correlation between HOMA and hypersensitivity C-reactive protein, interleukin-6 and resistin was analysised at the end of surgery and on the morning of postoperative day 1. Results There were no significant differences in age, sex ratio, BMI, and operative duration between both groups. To compare with before induction of anesthesia and the end of surgery, HCRP and IL-6 significantly increased on the morning of postoperative day 1 in both groups respectively (P<0.01). To compare with the end of surgery, FINS significantly increased on the morning of postoperative day 1 in both groups respectively (P<0.01). GA: from (20±10) to (30±12);GEA: from (18±7) to (26±10). To compare with before induction of anesthesia, FPG significantly increased at the end of surgery and on the morning of postoperative day 1 in both groups respectively (P<0.01). In the GEA, FPG significantly decreased at the end of surgery (6.4±1.4)and on the morning of postoperative day 1 (6.4±1.2)respectively (P<0.05). To compared with before induction of anesthesia and the end of surgery, HOMA significantly increased on the morning of postoperative day 1 in both groups respectively (P<0.01). In GEA group(2.3±1.6), HOMA significantly decreased (2.0±1.1)on the morning of postoperative day 1(P<0.05). In both groups, there was no significant change on RESIS and VAS. There were significant positive correlation between HOMA and hypersensitivity C-reactive protein and resistin at the end of surgery(r=0.61). While there were significiant positive correlation between HOMA and interleukin-6 and resistin on the morning of postoperative day 1(r=0.51). Conclusions Hemeostasis Model Assessment showed that (1) Insulin resistance decreased on the morning of postoperative day 1 with general anesthesia combined with epidural anesthesia and PCEA . (2) There were significant positive correlation between HOMA and hypersensitivity C-reactive protein and resistin at the end of surgery. While there were significiant positive correlation between HOMA and interleukin-6 and resistin on the morning of postoperative day 1.

Key words: General anesthesia; Epidural analgesia; Thoracic surgery; Insulin resistance; Hypersensitivity C-reactive protein; Interleukin-6; Resistin